Patients who recorded more walking activity prior to surgery, regardless of complexity of the operation or their health status, showed 51% reduced odds for postoperative complications than less active patients, according to research findings being presented at the American College of Surgeons Clinical Congress 2023.
Reviewed by Megan Craig, M.Sc.Oct 20 2023 Patients who recorded more walking activity prior to surgery, regardless of complexity of the operation or their health status, showed 51% reduced odds for postoperative complications than less active patients, according to research findings being presented at the American College of Surgeons Clinical Congress 2023.
Carson Gehl, lead study author, second-year medical student, Medical College of Wisconsin in Milwaukee "However, the fitness data wasn't limited to the immediate preoperative period. The length of their activity record could be six months or several years before surgery. This is more reflective of chronic physical activity habits, versus the physical activity in the immediate preoperative period."
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Steven Naismith reveals Euro 2024 dream as Hearts boss full of beliefThe 51-times capped former Scotland striker points to a squad which has grown together.
Read more »
Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients, trial showsA clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology.
Read more »
Scientists develop AI that can predict the life expectancy of cancer patientsCharities say that knowing how long you have left can help you make the most of your final years and 'plan' for death.
Read more »
Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial findsA drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.
Read more »
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancerCompared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy—given before and after surgery—significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).
Read more »
Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus: Clinical trialA secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo...
Read more »